Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations
Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
[PDF][PDF] Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations
A Werner-Lin, AL Ersig, R Mueller, JL Young… - 2018 - researchgate.net
Deleterious mutations in BRCA1 or BRCA2 genes increase a womanLs lifetime risk of
breast and ovarian cancer. Risk management guidelines endorse early detection and …
breast and ovarian cancer. Risk management guidelines endorse early detection and …
Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations
A Werner-Lin, AL Ersig, R Mueller… - Journal of …, 2018 - ingentaconnect.com
Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations
A Werner-Lin, AL Ersig, R Mueller… - Journal of …, 2018 - scholars.northwestern.edu
Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations
A Werner-Lin, AL Ersig, R Mueller… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.
A Werner-Lin, AL Ersig, R Mueller… - Journal of …, 2018 - europepmc.org
Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.
A Werner-Lin, AL Ersig, R Mueller… - Journal of …, 2018 - psycnet.apa.org
Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast
and ovarian cancer. Risk management guidelines endorse early detection and prevention …
and ovarian cancer. Risk management guidelines endorse early detection and prevention …